These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7913246)

  • 1. Cytokine dependence of human to mouse graft-versus-host disease.
    Huppes W; Fickenscher H; 'tHart BA; Fleckenstein B
    Scand J Immunol; 1994 Jul; 40(1):26-36. PubMed ID: 7913246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice.
    Hoffmann-Fezer G; Gall C; Zengerle U; Kranz B; Thierfelder S
    Blood; 1993 Jun; 81(12):3440-8. PubMed ID: 8099506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Xenogeneic Graft-Versus-Host Disease Model for Investigating the Pathological Role of Human CD4
    Ito R; Katano I; Kawai K; Yagoto M; Takahashi T; Ka Y; Ogura T; Takahashi R; Ito M
    Am J Transplant; 2017 May; 17(5):1216-1228. PubMed ID: 27862942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
    Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D
    Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC; Friedman TM; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells.
    Hilger N; Glaser J; Müller C; Halbich C; Müller A; Schwertassek U; Lehmann J; Ruschpler P; Lange F; Boldt A; Stahl L; Sack U; Oelkrug C; Emmrich F; Fricke S
    Cytometry A; 2016 Sep; 89(9):803-15. PubMed ID: 27560708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
    Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
    Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
    Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
    J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease.
    Roychowdhury S; Blaser BW; Freud AG; Katz K; Bhatt D; Ferketich AK; Bergdall V; Kusewitt D; Baiocchi RA; Caligiuri MA
    Blood; 2005 Oct; 106(7):2433-5. PubMed ID: 15976176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab.
    Chen X; Chang CH; Stein R; Cardillo TM; Gold DV; Goldenberg DM
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):28-39. PubMed ID: 23025988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute human vs. mouse graft vs. host disease in normal and immunodeficient mice.
    Huppes W; De Geus B; Zurcher C; Van Bekkum DW
    Eur J Immunol; 1992 Jan; 22(1):197-206. PubMed ID: 1730249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.
    Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X
    J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice.
    van Rijn RS; Simonetti ER; Hagenbeek A; Hogenes MC; de Weger RA; Canninga-van Dijk MR; Weijer K; Spits H; Storm G; van Bloois L; Rijkers G; Martens AC; Ebeling SB
    Blood; 2003 Oct; 102(7):2522-31. PubMed ID: 12791667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
    Zhang Y; Hexner E; Frank D; Emerson SG
    J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
    Schneider MK; Grönvik KO
    Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.